gemtuzumab ozogamicin   Click here for help

GtoPdb Ligand ID: 6775

Synonyms: CDP 771 | CMA 676 | hP67.6-calicheamicin | Mylotarg® | WAY-CMA 676
Approved drug Immunopharmacology Ligand
gemtuzumab ozogamicin is an approved drug (FDA (2000), EMA (2018))
Compound class: Antibody
Comment: This drug is an antibody-drug conjugate (ADC) that targets delivery of the highly cytotoxic ozogamicin (a derivative of calicheamicin γ1) to CD33 +ve myeloid cells [1].
Classification Click here for help
Compound class Antibody
Ligand families/groups Immune checkpoint modulators
Approved drug? Yes. FDA (2000)  |  EMA (2018)
International Nonproprietary Names Click here for help
INN number INN
10315 gemtuzumab ozogamicin
Synonyms Click here for help
CDP 771 | CMA 676 | hP67.6-calicheamicin | Mylotarg® | WAY-CMA 676
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 44
Other databases
GtoPdb PubChem SID 178103381
PubChem SID 178103381
Search PubMed clinical trials gemtuzumab ozogamicin
Search PubMed titles gemtuzumab ozogamicin
Search PubMed titles/abstracts gemtuzumab ozogamicin
Wikipedia Gemtuzumab_ozogamicin